Otitis Media: Review of the 2004 Treatment Guidelines

Abstract

Spanish

French

OBJECTIVE

To review the 2004 treatment guidelines provided by the American Academy of Pediatrics (AAP) and the American Academy of Family Physicians (AAFP) regarding the treatment of otitis media in pediatric patients.

DATA SOURCES

A MEDLINE search, restricted to English-language articles about pediatric patients, was conducted (1966–May 2005) using the key words acute otitis media (AOM), guideline, observation therapy, and vaccination. Additional references were located through review of the bibliographies of cited articles.

STUDY SELECTION AND DATA EXTRACTION

Studies related to the fundamental basis of the updated guidelines and articles addressing current issues related to otitis media infection were included.

DATA SYNTHESIS

Otitis media affects many children in the US. Concerns have been raised about the proper treatment of AOM in the face of increasing drug resistance among primary pathogens responsible for infection. Some countries have chosen to observe patients for a designated period of time prior to initiation of antibiotic therapy. The AAP and AAFP have updated the treatment guidelines for otitis media to include the option of observation therapy, recommendations for dosing of various antibiotic regimens and their place in therapy, and the importance of initial pain management.

CONCLUSIONS

Updated treatment guidelines for otitis media have been developed in an effort to properly treat children while decreasing current resistance rates for common organisms that cause AOM. In the future, the therapeutic outcomes of observation therapy related to both the incidence of drug resistance and the possibility of increased complications related to otitis media will need to be evaluated in the US.

Keywords

acute otitis media guideline observation therapy vaccination

Get full access to this article

View all access options for this article.

References

1. Rovers

, Schilder

AGM

, Zielhuis

, Rosenfeld

. Otitis media. Lancet 2004; 363: 465–73. DOI 10.1016/S0140-6736(04)15495-0

2. Jacobs

. Prevention of otitis media: role of pneumococcal conjugate vaccines in reducing incidence and antibiotic resistance. J Pediatr 2002; 141: 287–93. DOI 10.1067/mpd.2002.125730

3. Jacobs

. Judicious use of antibiotics for common pediatric respiratory infections. Pediatr Infect Dis J 2000; 19: 938–43.

4. American Academy of Pediatrics and American Academy of Family Physicians. Questions and answers on acute otitis media. www.aafp.org/x26481.xml (accessed 2005 Mar 5).

5. Marcy

, Takata

, Chan

, Shekelle

, Mason

, Wachsman

, Management of acute otitis media. Evid Rep Technol Assess (Summ) 2000; Jun (15):1–4. www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1.chapter.21026 (accessed 2005 Mar 24).

6. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004; 113: 1451–65. DOI 10.1542/peds.113.5.1451

7. Hoppe

, Johnson

. Otitis media: focus on antimicrobial resistance and new treatment options. Am J Health Syst Pharm 1998; 55: 1881–97.

8. Pichichero

. Recurrent and persistent otitis media. Pediatr Infect Dis J 2000; 19: 911–6.

9. Hoberman

, Paradise

. Acute otitis media: diagnosis and management in the year 2000. Pediatr Ann 2000; 29: 609–20.

10.

10. Daly

, Giebink

. Clinical epidemiology of otitis media. Pediatr Infect Dis J 2000; 19 (5 suppl): S31–6.

11.

11. Alho

, Koivu

, Sorri

, Rantakallio

. Risk factors for recurrent acute otitis media and respiratory infection in infancy. Int J Pediatr Otorhinolaryngol 1990; 19: 151–61.

12.

12. Daly

, Rich

, Levine

, Margolis

, Le

, Lindgren

, The family study of otitis media: design and disease and risk factor profiles. Genet Epidemiol 1996; 13: 451–68. DOI 10.1002/(SICI)1098-2272 (1996)13:5<451::AID-GEPI2>3.0.CO; 2–5

13.

13. Lanphear

B P

, Byrd

, Auinger

, Hall

. Increasing prevalence of recurrent otitis media among children in the United States. Pediatrics 1997; 99 (suppl): E1. DOI 10.1542/peds.99.3.e1

14.

14. Curns

, Holman

, Shay

, Cheek

, Kaufman

, Singleton

. Outpatient and hospital visits associated with otitis media among American Indian and Alaska native children younger than 5 years. Pediatrics 2002; 109 (suppl): E41–1. DOI 10.1542/peds.109.3.e41

15.

15. Aniansson

, Svensson

, Becker

, Ingvarsson

. Otitis media and feeding with breast milk of children with cleft palate. Scand J Plast Reconstr Surg Hand Surg 2002; 36: 9–15.

16.

16. American Academy of Pediatrics Work Group on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 1997; 100: 1035–9. DOI 10.1542/peds.100.6.1035

17.

17. Lawrence

, Howard

. Given the benefits of breastfeeding, are there any contraindications? Clin Perinatol 1999; 26: 479–90, viii.

18.

18. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108: 776–89.

19.

19. Duncan

. Positional otitis media. Arch Otolaryngol 1960; 72: 454–63.

20.

20. Warren

, Levy

, Kirchner

, Nowak

, Bergus

. Pacifier use and the occurrence of otitis media in the first year of life. Pediatr Dent 2001; 23: 103–7.

21.

21. Garrelts

, Melnyk

. Pacifier usage and acute otitis media in infants and young children. Pediatr Nurs 2001; 27: 516–8, 491.

22.

22. Niemela

, Uhari

, Mottonen

. A pacifier increases the risk of recurrent acute otitis media in children in daycare centers. Pediatrics 1995; 96 (5 pt 1): 884–8.

23.

23. Niemela

, Uhari

, Hannuksela

. Pacifiers and dental structure as risk factors for otitis media. Int J Pediatr Otorhinolaryngol 1994; 29: 121–7. DOI 10.1016/0165-5876(94)90091-4

24.

24. Klein

. Otitis media. Clin Infect Dis 1994; 19: 823–33.

25.

25. Darkes

, Plosker

. Pneumococcal conjugate vaccine (Prevnar; PN-CRM7): a review of its use in the prevention of Streptococcus pneumoniae infection. Paediatr Drugs 2002; 4: 609–30.

26.

26. Block

, Hedrick

, Harrison

, Tyler

, Smith

, Findlay

, Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004; 23: 829–33. DOI 10.1097/01.inf.0000138453.32886.a6

27.

27. Casey

, Pichichero

. Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J 2004; 23: 824–8. DOI 10.1097/01.inf.0000136871.51792.19

28.

28. Heikkinen

. Role of viruses in the pathogenesis of acute otitis media. Pediatr Infect Dis J 2000; 19 (5 suppl): S17–22.

29.

29. Heikkinen

, Chonmaitree

. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev 2003; 16: 230–41. DOI 10.1128/CMR.16.2.230-241.2003

30.

30. Rovers

, Straatman

, Zielhuis

, Ingels

, van der Wilt

. Seasonal variation in the prevalence of persistent otitis media with effusion in one-year-old infants. Paediatr Perinat Epidemiol 2000; 14: 268–74. DOI 10.1046/j.1365–3016.2000.00271.x

31.

31. Castagno

, Lavinsky

. Otitis media in children: seasonal changes and socioeconomic level. Int J Pediatr Otorhinolaryngol 2002; 62: 129–34. DOI 10.1016/S0165–5876(01)00607–3

32.

32. Pichichero

. Acute otitis media: part II. Treatment in an era of increasing antibiotic resistance. Am Fam Physician 2000; 61: 2410–6.

33.

33. Doern

, Pfaller

, Kugler

, Freeman

, Jones

. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 1998; 27: 764–70.

34.

34. Jacobs

, Felmingham

, Appelbaum

, Gruneberg

. The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52: 229–46. DOI 10.1093/jac/dkg321

35.

35. Doern

, Jones

, Pfaller

, Kugler

. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1999; 43: 385–9.

36.

36. Barnett

. Antibiotic resistance and choice of antimicrobial agents for acute otitis media. Pediatr Ann 2002; 31: 794–9.

37.

37. Dagan

, Leibovitz

, Leiberman

, Yagupsky

. Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms. Pediatr Infect Dis J 2000; 19 (5 suppl): S57–65.

38.

38. Pichichero

. Acute otitis media: part I. Improving diagnostic accuracy. Am Fam Physician 2000; 61: 2051–6.

39.

39. Bluestone

. Role of surgery for otitis media in the era of resistant bacteria. Pediatr Infect Dis J 1998; 17: 1090–8.

40.

40. MacClements

, Parachman

, Passmore

. Otitis media in children: use of diagnostic tools by family practice residents. Fam Med 2002; 34: 598–603.

41.

41. Pichichero

, Poole

. Assessing diagnostic accuracy and tympanocentesis skills in the management of otitis media. Arch Pediatr Adolesc Med 2001; 155: 1137–42.

42.

42. Dowell

, Marcy

, Phillips

, Gerber MA Schwartz

. Otitis media—principles of judicious use of antimicrobial agents. Pediatrics 1998; 101 (1 suppl): 165–71.

43.

43. Bertin

, Pons

, d'Athis

, Duhamel

, Maudelonde

, Lasfargues

, A randomized, double-blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children. Fundam Clin Pharmacol 1996; 10: 387–92.

44.

44. Pelton

. Acute otitis media in an era of increasing antimicrobial resistance and universal administration of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2002; 21: 599–604. DOI 10.1097/01.inf.0000016464.49739.94

45.

45. Schilder

AGM

, Lok

, Rovers

. International perspectives on management of acute otitis media: a qualitative review. Int J Pediatr Otorhinolaryngol 2004; 68: 29–36. DOI 10.1016/j.ijporl.2003.09.002

46.

46. Little

, Gould

, Williamson

, Moore

, Warner

, Dunleavey

. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ 2001; 322: 336–42. DOI 10.1136/bmj.322.7682.336

47.

47. Damoiseaux

RAMJ

, van Balen

RAM

, Hoes

, Verheij

TJM

, de Melker

. Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ 2000; 320: 350–4. DOI 10.1136/bmj.320.7231.350

48.

48. Little

, Gould

, Moore

, Warner

, Dunleavey

, Williamson

. Predictors of poor outcome and benefits from antibiotics in children with acute otitis media: pragmatic randomised trial. BMJ 2002; 325: 22.

49.

49. Siegel

, Kiely

, Bien

, Joseph

, Davis

, Mendel

, Treatment of otitis media with observation and a safety-net antibiotic prescription. Pediatrics 2003; 112 (3 pt 1): 527–31. DOI 10.1542/peds.112.3.527

50.

50. Dowell

, Butler

, Giebink

, Jacobs

, Jernigan

, Musher

, Acute otitis media: management and surveillance in an era of pneumococcal resistance—a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999; 18: 1–9.

51.

51. Taketomo

, Hodding

, Kraus

, eds. Lexi-Comp's Pediatric Dosing Handbook. Hudson, OH: Lexi-Comp, 2004.

52.

52. Marchisio

, Cavagna

, Maspes

, Gironi

, Esposito

, Lambertini

, Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis 2002; 35: 168–74.

53.

53. Eskola

, Kilpi

, Palmu

, Jokinen

, Haapakoski

, Herva

, Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344: 403–9.

54.

54. Black

, Shinefield

, Fireman

, Lewis

, Ray

, Hansen

, Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19: 187–95.

55.

55. Veenhoven

, Bogaert

, Uiterwaal

, Brouwer

, Kiezebrink

, Bruin

, Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 2003; 361: 2189–95. DOI 10.1016/S0140-6736(03)13772-5

56.

56. Harrison

. The laws of acute otitis media. Prim Care 2003; 30: 109–35.

57.

57. Cates

. An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study. BMJ 1999; 318: 715–6.

58.

58. Bluestone

. Clinical course, complications and sequelae of acute otitis media. Pediatr Infect Dis J 2000; 19 (5 suppl): S37–46.

59.

59. van Buchem

, Peeters

, van't Hof

. Acute otitis media: a new treatment strategy. Br Med J (Clin Res Ed) 1985; 290: 1033–7.

60.

60. van Buchem

, Dunk

, van't Hof

. Therapy of acute otitis media: myringotomy, antibiotics, or neither? A double-blind study in children. Lancet 1981; 2: 883–7.